Evidence map›Paper›PMID 31175460›Full record

ArticleWorld journal of urology2020

One-Stop MRI and MRI/transrectal ultrasound fusion-guided biopsy: an expedited pathway for prostate cancer diagnosis.

Alessandro Tafuri, Akbar N Ashrafi, Suzanne Palmer, Aliasger Shakir, Giovanni E Cacciamani, Atsuko Iwata, Tsuyoshi Iwata, Jie Cai, Akash Sali, Chhavi Gupta and 6 more

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in World journal of urology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.7field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. A nomogram to predict the absence of clinically significant prostate cancer in males with negative MRIInternational braz j urol : official journal of the Brazilian Society of Urology
    Article
  13. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 1 institution in 2 countries.

Alessandro TafuriUSC Institute of Urology and Catherine and Joseph Aresty Department of Urology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Akbar N AshrafiUSC Institute of Urology and Catherine and Joseph Aresty Department of Urology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Suzanne PalmerDepartment of Radiology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Aliasger ShakirUSC Institute of Urology and Catherine and Joseph Aresty Department of Urology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Giovanni E CacciamaniUSC Institute of Urology and Catherine and Joseph Aresty Department of Urology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Atsuko IwataUSC Institute of Urology and Catherine and Joseph Aresty Department of Urology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Tsuyoshi IwataUSC Institute of Urology and Catherine and Joseph Aresty Department of Urology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Jie CaiUSC Institute of Urology and Catherine and Joseph Aresty Department of Urology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Akash SaliUSC Institute of Urology and Catherine and Joseph Aresty Department of Urology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Chhavi GuptaUSC Institute of Urology and Catherine and Joseph Aresty Department of Urology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Luis G MedinaUSC Institute of Urology and Catherine and Joseph Aresty Department of Urology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Mariana C SternUSC Institute of Urology and Catherine and Joseph Aresty Department of Urology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Vinay DuddalwarDepartment of Radiology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Manju AronDepartment of Pathology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Inderbir S GillUSC Institute of Urology and Catherine and Joseph Aresty Department of Urology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Andre AbreuUSC Institute of Urology and Catherine and Joseph Aresty Department of Urology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA. Andre.Abreu@med.usc.edu.ORCID http://orcid.org/0000-0002-9167-2587
University of Southern California · US

Funding

Diagnosing clinically-significant prostate cancer in African American men: Systematic random versus MR-image-fusion guided biopsyR01CA205058 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI GILL, INDERBIR, STERN, MARIANA C · 2016 to 2019
$2.1M
Foundation for the National Institutes of Health CA205058-01NCI NIH HHS R01 CA205058
6 · The paper itself

Abstract

purposeTo assess the feasibility, safety, and outcomes of an expedited One-Stop prostate cancer (PCa) diagnostic pathway. PATIENTS AND

methodsWe identified 370 consecutive patients who underwent multiparametric magnetic resonance imaging (mpMRI) and transrectal ultrasound fusion prostate biopsy (MRI/TRUS-PBx) from our institutional review board-approved database. Patients were divided according to diagnostic pathway: One-Stop (n = 74), with mpMRI and same-day PBx, or Standard (n = 296), with mpMRI followed by a second visit for PBx. mpMRIs were performed and interpreted according to Prostate Imaging-Reporting and Data System (PI-RADS v2). Grade group ≥ 2 PCa defined clinically significant PCa (csPCa). Statistical significance was considered when p < 0.05.

resultsAge (66 vs 66 years, p = 0.59) and PSA density (0.1 vs 0.1 ng/mL

conclusionA One-Stop PCa diagnostic pathway is feasible, safe, and provides similar outcomes in a shorter time compared to the Standard two-visit diagnostic pathway.

Indexed as

Magnetic Resonance Imaging, InterventionalUltrasonography, InterventionalAgedFeasibility StudiesHumansImage-Guided BiopsyMaleMiddle AgedMultimodal ImagingMultiparametric Magnetic Resonance ImagingProstatic NeoplasmsRectumRetrospective StudiesMRIMRI fusion biopsyOne-StopProstate biopsyProstate cancer

Identifiers

PMID31175460
PMCPMC6898759
OpenAlexW2954499977

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.